In AD, the “cholinergic hypothesis” is the most accepted theory, thus the inhibition of acetylcholinesterase (AchE) might alleviate the progressive deficiency of acetylcholine (ACh) levels that characterizes the pathology [21]. This evidence concerns the gene ACHE and Alzheimer disease.